Rapamycin May Slow Skin Aging, Drexel Study Reports
The search for youthfulness typically turns to lotions, supplements, serums and diets, but there may soon be a new option joining the fray. Rapamycin, an FDA-approved drug normally used to prevent organ rejection after transplant surgery, may also slow aging in human skin, according to a Drexel study published in Geroscience.
An Exhibit Epitaph Honoring 171 Years of Hahnemann History
The Drexel Collection, in collaboration with the College of Medicine's Legacy Center Archives, has unveiled Honoring the Hahnemann Community, which recognizes the pioneering legacy of Hahnemann University Hospital from 1848 to 2019.